2028 Marketing Pharmaceuticals Vaccine 
Drug Discovery World
JULY 25, 2024
According to data analysts Precedence Research, the global biotechnology market was estimated at $1.38 Following a subdued 2022 and 2023 for biotech investment, there is optimism that the market is heading to recovery in 2024. In 2021, the country had the seventh largest share of the global biotech market 2.
Drug Discovery World
MAY 1, 2024
UBS China healthcare analyst Chen Chen said the price increase was due to “booming investment” in drug discovery in the first two years of the Covid-19 pandemic as a result of efforts to develop vaccines. However, data from Statista predict a recovery in 2024, with the value of the Chinese pharmaceuticals sector increasing from $110.77
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
MARCH 13, 2024
According to Statista, revenue in this sector is expected to grow at an annual rate of 6.77%, resulting in a market volume of US$2,208m by 2028 1. Singapore is among a few countries worldwide whose pharmaceutical export value far exceed the import value. UK-based molecular diagnostics group Yourgene operates in Singapore.
Drug Discovery World
AUGUST 8, 2023
In the global pharmaceuticals market, India ranks third worldwide for production by volume and the domestic pharmaceutical market is expected to reach US$120-130 billion by 2030 1. Similarly, The Times of India says that branded generic medicines have “long fuelled India’s pharmaceutical exports” 4.
The Pharma Data
JANUARY 9, 2021
We are proud to be a leader in the growing public health threat market, enabled by our development and manufacturing expertise, successful public-private partnerships, and broad portfolio of products and CDMO services. • Anthrax Vaccines. Adjusted Net Income (1). .
Codon
SEPTEMBER 29, 2024
2028 Over the next year, the scientific community ferociously interrogated the model. Marketed as a gesture of scientific goodwill, it also gave the companies the benefit of further academic research into their models free of charge. The trained model also went live on HuggingFace , open for both academic and commercial usage.
The Pharma Data
SEPTEMBER 15, 2020
27 key programs highlighted, including assets that could potentially contribute revenue by 2025 and others in the 2026-2028 time frame. Major revenue contributions through 2025 anticipated from Oncology, Vaccines, Rare Disease and Inflammation and Immunology. BNT162 mRNA-based Vaccine Program.
Expert insights. Personalized for you.
130 
Let's personalize your content